Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02299414 · ClinicalTrials.gov registry record · Phase 4
Chronic Hypertension and Pregnancy (CHAP) Project
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,408
- Enrollment target
NCT02299414 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 2,408 participants.
The verdict
NCT02299414, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,408 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (\<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
Interventions
- DRUG Anti-hypertensive therapy
- OTHER No anti-hypertensive therapy (unless BP is severe)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,408 participants |
| Start Date | 2015-06 |
| Est. Completion | 2022-12-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02299414
The ClinicalTrials.gov registry entry for NCT02299414 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 2,408 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Anti-hypertensive therapy is the first listed.
NCT02299414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02299414 about?
NCT02299414 is a clinical study titled "Chronic Hypertension and Pregnancy (CHAP) Project". The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (\<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective ...
What is the current status of trial NCT02299414?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,408 participants. The study started on 2015-06. Estimated completion is 2022-12-16.
What interventions are being tested in trial NCT02299414?
The interventions under investigation include: Anti-hypertensive therapy (DRUG), No anti-hypertensive therapy (unless BP is severe) (OTHER).
Who is sponsoring clinical trial NCT02299414?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.